The authors apologise for errors which appear in the legend of Figure 2. Please find below the corrected legend.
Fig. 2. ED50 of Aureobasidin A (AbA, A-D) or Compound 20 (Cpmd 20, E-H) – µg mL−1; (95% Confidence Interval) – against the Toxoplasma RH tachyzoite form in HFF cells. 6 days post addition of the compounds. In agreement with Sonda et al. (2005), both compounds were non-toxic to HHF cells under the conditions employed. A and E: no wash out post-compound addition; B and F: wash out 2 h post-compound addition; C and G: wash out 8 h post-compound addition; D and H: 2 h pre-treatment of isolated parasites pre-infection. Calculated using GraphPad Prism 7, log (inhibitor) vs normalized response – Variable slope. >10 µg mL−1 – ED50 could not be determined. Representative in triplicate dataset.
REFERENCE
- Alqaisi A. Q. I., Mbekeani A. J., Bassas Llorens M., Elhammer A. P. and Denny P. W. (2017). The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis Parasitology. Published by Cambridge University Press, 10 May 2017. doi: 10.1017/S0031182017000506. [DOI] [PMC free article] [PubMed] [Google Scholar]